Vestal Point Capital’s Axsome Therapeutics AXSM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-300,000	Closed	-$24.2M	–	71
2024 Q2	$24.2M	Buy	+300,000	New	+$24.2M	1.8%	18